0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Gene Cloning Technology Services Market Outlook, In‑Depth Analysis & Forecast to 2031
Published Date: November 2025
|
Report Code: QYRE-Auto-31G16725
Home | Market Reports | Computers & Electronics| Software
Global Gene Cloning Technology Services Market Research Report 2024
BUY CHAPTERS

Global Gene Cloning Technology Services Market Outlook, In‑Depth Analysis & Forecast to 2031

Code: QYRE-Auto-31G16725
Report
November 2025
Pages:137
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Gene Cloning Technology Services Market

The global Gene Cloning Technology Services market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
From a downstream perspective, Laboratory accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).
Gene Cloning Technology Services leading manufacturers including VectorBuilder, BioServUK, GenScript, urofins Genomics, Innoprot, Genewiz, Bio-Fab Research, OriGene, Prospec-Tany Technogene, Addgene, etc., dominate supply; the top five capture approximately % of global revenue, with VectorBuilder leading 2024 sales at US$ million.
Regional Outlook:
North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).
Asia‑Pacific will expand from US$ million to US$ million (CAGR  %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).
Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).

Report Includes:

This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Gene Cloning Technology Services market across value chain. It analyzes historical revenue data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies market size, growth rates, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries, detailing dominant products, competitive landscape, and downstream demand trends.
Critical competitive intelligence profiles players—revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise Industry‑chain overview maps upstream, middlestream, and downstream distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation

Scope of Gene Cloning Technology Services Market Report

Report Metric Details
Report Name Gene Cloning Technology Services Market
Segment by Type
  • Basic Gene Cloning Service
  • Custom Gene Cloning Services
Segment by Application
  • Laboratory
  • Research Institute
  • Others
Sales by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company VectorBuilder, BioServUK, GenScript, urofins Genomics, Innoprot, Genewiz, Bio-Fab Research, OriGene, Prospec-Tany Technogene, Addgene, Protein Ark, Protomnis, RD-Biotech, Charles River
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the Gene Cloning Technology Services study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
  • Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
  • Chapter 3: Dissects the player landscape—ranks by revenue and profitability, details Player performance by product type and evaluates concentration alongside M&A moves.
  • Chapter 4: Unlocks high margin product segments—compares revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
  • Chapter 5: Targets downstream market opportunities—evaluates market size by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
  • Chapter 6: North America—breaks down market size by Type, by Application and country, profiles key players and assesses growth drivers and barriers.
  • Chapter 7: Europe—analyses regional market by Type, by Application and players, flagging drivers and barriers.
  • Chapter 8: Asia Pacific—quantifies market size by Type, by Application, and region/country, profiles top players, and uncovers high potential expansion areas.
  • Chapter 9: Central & South America—measures market size by Type, by Application, and country, profiles top players, and identifies investment opportunities and challenges.
  • Chapter 10: Middle East and Africa—evaluates market size by Type, by Application, and country, profiles key players, and outlines investment prospects and market hurdles
  • Chapter 11: Profiles players in depth—details product specs, revenue, margins; Top-tier players 2024 sales breakdowns by Product type, by Application, by region SWOT analysis, and recent strategic developments.
  • Chapter 12: Industry chain—analyses upstream, cost drivers, plus downstream channels.
  • Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
  • Chapter 14: Actionable conclusions and strategic recommendations.
  • Why This Report:
  • Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
  • Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
  • Negotiate from strength with suppliers (Chapter 12) and customers (Chapter 5) using cost and demand intelligence.
  • Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
  • Capitalize on the projected billion‑dollar opportunity with data‑driven regional and segment tactics (Chapter 12-14).
  • Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

FAQ for this report

Who are the main players in the Gene Cloning Technology Services Market report?

Ans: The main players in the Gene Cloning Technology Services Market are VectorBuilder, BioServUK, GenScript, urofins Genomics, Innoprot, Genewiz, Bio-Fab Research, OriGene, Prospec-Tany Technogene, Addgene, Protein Ark, Protomnis, RD-Biotech, Charles River

What are the Application segmentation covered in the Gene Cloning Technology Services Market report?

Ans: The Applications covered in the Gene Cloning Technology Services Market report are Laboratory, Research Institute, Others

What are the Type segmentation covered in the Gene Cloning Technology Services Market report?

Ans: The Types covered in the Gene Cloning Technology Services Market report are Basic Gene Cloning Service, Custom Gene Cloning Services

1 Study Coverage
1.1 Introduction to Gene Cloning Technology Services: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Gene Cloning Technology Services Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Basic Gene Cloning Service
1.2.3 Custom Gene Cloning Services
1.3 Market Segmentation by Application
1.3.1 Global Gene Cloning Technology Services Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Laboratory
1.3.3 Research Institute
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Gene Cloning Technology Services Revenue Estimates and Forecasts 2020-2031
2.2 Global Gene Cloning Technology Services Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020-2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.2.4 Emerging Market Focus: Growth Drivers & Investment Trends
3 Competition by Players
3.1 Global Gene Cloning Technology Services Player Revenue Rankings and Profitability
3.1.1 Global Revenue (Value) by Players (2020-2025)
3.1.2 Global Key Player Revenue Ranking (2023 vs. 2024)
3.1.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.1.4 Gross Margin by Top Player (2020 VS 2024)
3.2 Global Gene Cloning Technology Services Companies Headquarters and Service Footprint
3.3 Main Product Type Market Size by Players
3.3.1 Basic Gene Cloning Service Market Size by Players
3.3.2 Custom Gene Cloning Services Market Size by Players
3.4 Global Gene Cloning Technology Services Market Concentration and Dynamics
3.4.1 Global Market Concentration (CR5 and HHI)
3.4.2 Entrant/Exit Impact Analysis
3.4.3 Strategic Moves: M&A, Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Gene Cloning Technology Services Revenue Trends by Type
4.1.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.1.2 Global Revenue Market Share by Type (2020-2031)
4.2 Key Product Attributes and Differentiation
4.3 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.3.1 High-Growth Niches and Adoption Drivers
4.3.2 Profitability Hotspots and Cost Drivers
4.3.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Gene Cloning Technology Services Revenue by Application
5.1.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.1.2 Revenue Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Downstream Customer Analysis
5.2.1 Top Customers by Region
5.2.2 Top Customers by Application
6 North America
6.1 North America Market Size (2020-2031)
6.2 North America Key Players Revenue in 2024
6.3 North America Gene Cloning Technology Services Market Size by Type (2020-2031)
6.4 North America Gene Cloning Technology Services Market Size by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Gene Cloning Technology Services Market Size by Country
6.6.1 North America Revenue Trends by Country
6.6.2 US
6.6.3 Canada
6.6.4 Mexico
7 Europe
7.1 Europe Market Size (2020-2031)
7.2 Europe Key Players Revenue in 2024
7.3 Europe Gene Cloning Technology Services Market Size by Type (2020-2031)
7.4 Europe Gene Cloning Technology Services Market Size by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Gene Cloning Technology Services Market Size by Country
7.6.1 Europe Revenue Trends by Country
7.6.2 Germany
7.6.3 France
7.6.4 U.K.
7.6.5 Italy
7.6.6 Russia
8 Asia-Pacific
8.1 Asia-Pacific Market Size (2020-2031)
8.2 Asia-Pacific Key Players Revenue in 2024
8.3 Asia-Pacific Gene Cloning Technology Services Market Size by Type (2020-2031)
8.4 Asia-Pacific Gene Cloning Technology Services Market Size by Application (2020-2031)
8.5 Asia-Pacific Growth Accelerators and Market Barriers
8.6 Asia-Pacific Gene Cloning Technology Services Market Size by Region
8.6.1 Asia-Pacific Revenue Trends by Region
8.7 China
8.8 Japan
8.9 South Korea
8.10 Australia
8.11 India
8.12 Southeast Asia
8.12.1 Indonesia
8.12.2 Vietnam
8.12.3 Malaysia
8.12.4 Philippines
8.12.5 Singapore
9 Central and South America
9.1 Central and South America Market Size (2020-2031)
9.2 Central and South America Key Players Revenue in 2024
9.3 Central and South America Gene Cloning Technology Services Market Size by Type (2020-2031)
9.4 Central and South America Gene Cloning Technology Services Market Size by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Gene Cloning Technology Services Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Market Size (2020-2031)
10.2 Middle East and Africa Key Players Revenue in 2024
10.3 Middle East and Africa Gene Cloning Technology Services Market Size by Type (2020-2031)
10.4 Middle East and Africa Gene Cloning Technology Services Market Size by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Gene Cloning Technology Services Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Israel
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 VectorBuilder
11.1.1 VectorBuilder Corporation Information
11.1.2 VectorBuilder Business Overview
11.1.3 VectorBuilder Gene Cloning Technology Services Product Features and Attributes
11.1.4 VectorBuilder Gene Cloning Technology Services Revenue and Gross Margin (2020-2025)
11.1.5 VectorBuilder Gene Cloning Technology Services Revenue by Product in 2024
11.1.6 VectorBuilder Gene Cloning Technology Services Revenue by Application in 2024
11.1.7 VectorBuilder Gene Cloning Technology Services Revenue by Geographic Area in 2024
11.1.8 VectorBuilder Gene Cloning Technology Services SWOT Analysis
11.1.9 VectorBuilder Recent Developments
11.2 BioServUK
11.2.1 BioServUK Corporation Information
11.2.2 BioServUK Business Overview
11.2.3 BioServUK Gene Cloning Technology Services Product Features and Attributes
11.2.4 BioServUK Gene Cloning Technology Services Revenue and Gross Margin (2020-2025)
11.2.5 BioServUK Gene Cloning Technology Services Revenue by Product in 2024
11.2.6 BioServUK Gene Cloning Technology Services Revenue by Application in 2024
11.2.7 BioServUK Gene Cloning Technology Services Revenue by Geographic Area in 2024
11.2.8 BioServUK Gene Cloning Technology Services SWOT Analysis
11.2.9 BioServUK Recent Developments
11.3 GenScript
11.3.1 GenScript Corporation Information
11.3.2 GenScript Business Overview
11.3.3 GenScript Gene Cloning Technology Services Product Features and Attributes
11.3.4 GenScript Gene Cloning Technology Services Revenue and Gross Margin (2020-2025)
11.3.5 GenScript Gene Cloning Technology Services Revenue by Product in 2024
11.3.6 GenScript Gene Cloning Technology Services Revenue by Application in 2024
11.3.7 GenScript Gene Cloning Technology Services Revenue by Geographic Area in 2024
11.3.8 GenScript Gene Cloning Technology Services SWOT Analysis
11.3.9 GenScript Recent Developments
11.4 urofins Genomics
11.4.1 urofins Genomics Corporation Information
11.4.2 urofins Genomics Business Overview
11.4.3 urofins Genomics Gene Cloning Technology Services Product Features and Attributes
11.4.4 urofins Genomics Gene Cloning Technology Services Revenue and Gross Margin (2020-2025)
11.4.5 urofins Genomics Gene Cloning Technology Services Revenue by Product in 2024
11.4.6 urofins Genomics Gene Cloning Technology Services Revenue by Application in 2024
11.4.7 urofins Genomics Gene Cloning Technology Services Revenue by Geographic Area in 2024
11.4.8 urofins Genomics Gene Cloning Technology Services SWOT Analysis
11.4.9 urofins Genomics Recent Developments
11.5 Innoprot
11.5.1 Innoprot Corporation Information
11.5.2 Innoprot Business Overview
11.5.3 Innoprot Gene Cloning Technology Services Product Features and Attributes
11.5.4 Innoprot Gene Cloning Technology Services Revenue and Gross Margin (2020-2025)
11.5.5 Innoprot Gene Cloning Technology Services Revenue by Product in 2024
11.5.6 Innoprot Gene Cloning Technology Services Revenue by Application in 2024
11.5.7 Innoprot Gene Cloning Technology Services Revenue by Geographic Area in 2024
11.5.8 Innoprot Gene Cloning Technology Services SWOT Analysis
11.5.9 Innoprot Recent Developments
11.6 Genewiz
11.6.1 Genewiz Corporation Information
11.6.2 Genewiz Business Overview
11.6.3 Genewiz Gene Cloning Technology Services Product Features and Attributes
11.6.4 Genewiz Gene Cloning Technology Services Revenue and Gross Margin (2020-2025)
11.6.5 Genewiz Recent Developments
11.7 Bio-Fab Research
11.7.1 Bio-Fab Research Corporation Information
11.7.2 Bio-Fab Research Business Overview
11.7.3 Bio-Fab Research Gene Cloning Technology Services Product Features and Attributes
11.7.4 Bio-Fab Research Gene Cloning Technology Services Revenue and Gross Margin (2020-2025)
11.7.5 Bio-Fab Research Recent Developments
11.8 OriGene
11.8.1 OriGene Corporation Information
11.8.2 OriGene Business Overview
11.8.3 OriGene Gene Cloning Technology Services Product Features and Attributes
11.8.4 OriGene Gene Cloning Technology Services Revenue and Gross Margin (2020-2025)
11.8.5 OriGene Recent Developments
11.9 Prospec-Tany Technogene
11.9.1 Prospec-Tany Technogene Corporation Information
11.9.2 Prospec-Tany Technogene Business Overview
11.9.3 Prospec-Tany Technogene Gene Cloning Technology Services Product Features and Attributes
11.9.4 Prospec-Tany Technogene Gene Cloning Technology Services Revenue and Gross Margin (2020-2025)
11.9.5 Prospec-Tany Technogene Recent Developments
11.10 Addgene
11.10.1 Addgene Corporation Information
11.10.2 Addgene Business Overview
11.10.3 Addgene Gene Cloning Technology Services Product Features and Attributes
11.10.4 Addgene Gene Cloning Technology Services Revenue and Gross Margin (2020-2025)
11.10.5 Company Ten Recent Developments
11.11 Protein Ark
11.11.1 Protein Ark Corporation Information
11.11.2 Protein Ark Business Overview
11.11.3 Protein Ark Gene Cloning Technology Services Product Features and Attributes
11.11.4 Protein Ark Gene Cloning Technology Services Revenue and Gross Margin (2020-2025)
11.11.5 Protein Ark Recent Developments
11.12 Protomnis
11.12.1 Protomnis Corporation Information
11.12.2 Protomnis Business Overview
11.12.3 Protomnis Gene Cloning Technology Services Product Features and Attributes
11.12.4 Protomnis Gene Cloning Technology Services Revenue and Gross Margin (2020-2025)
11.12.5 Protomnis Recent Developments
11.13 RD-Biotech
11.13.1 RD-Biotech Corporation Information
11.13.2 RD-Biotech Business Overview
11.13.3 RD-Biotech Gene Cloning Technology Services Product Features and Attributes
11.13.4 RD-Biotech Gene Cloning Technology Services Revenue and Gross Margin (2020-2025)
11.13.5 RD-Biotech Recent Developments
11.14 Charles River
11.14.1 Charles River Corporation Information
11.14.2 Charles River Business Overview
11.14.3 Charles River Gene Cloning Technology Services Product Features and Attributes
11.14.4 Charles River Gene Cloning Technology Services Revenue and Gross Margin (2020-2025)
11.14.5 Charles River Recent Developments
12 Gene Cloning Technology ServicesIndustry Chain Analysis
12.1 Gene Cloning Technology Services Industry Chain
12.2 Upstream Analysis
12.2.1 Upstream Key Suppliers
12.3 Middlestream Analysis
12.4 Downstream Sales Model and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Gene Cloning Technology Services Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Gene Cloning Technology Services Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
List of Tables
 Table 1. Global Gene Cloning Technology Services Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Table 2. Global Gene Cloning Technology Services Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Table 3. Global Gene Cloning Technology Services Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 4. Global Gene Cloning Technology Services Revenue by Region (2020-2025) & (US$ Million)
 Table 5. Global Gene Cloning Technology Services Revenue by Region (2026-2031) & (US$ Million)
 Table 6. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 7. Global Gene Cloning Technology Services Revenue by Players (2020-2025) & (US$ Million)
 Table 8. Global Gene Cloning Technology Services Revenue Market Share by Players (2020-2025)
 Table 9. Global Key Players’Ranking Shift (2023 vs. 2024) (Based on Revenue)
 Table 10. Global Gene Cloning Technology Services by Player Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gene Cloning Technology Services as of 2024)
 Table 11. Global Gene Cloning Technology Services Average Gross Margin (%) by Player (2020 VS 2024)
 Table 12. Global Gene Cloning Technology Services Companies Headquarters
 Table 13. Global Gene Cloning Technology Services Market Concentration Ratio (CR5 and HHI)
 Table 14. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
 Table 15. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
 Table 16. Global Gene Cloning Technology Services Revenue by Type (2020-2025) & (US$ Million)
 Table 17. Global Gene Cloning Technology Services Revenue by Type (2026-2031) & (US$ Million)
 Table 18. Key Product Attributes and Differentiation
 Table 19. Global Gene Cloning Technology Services Revenue by Application (2020-2025) & (US$ Million)
 Table 20. Global Gene Cloning Technology Services Revenue by Application (2026-2031) & (US$ Million)
 Table 21. Gene Cloning Technology Services High-Growth Sectors Demand CAGR (2024-2031)
 Table 22. Top Customers by Region
 Table 23. Top Customers by Application
 Table 24. North America Gene Cloning Technology Services Growth Accelerators and Market Barriers
 Table 25. North America Gene Cloning Technology Services Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 26. Europe Gene Cloning Technology Services Growth Accelerators and Market Barriers
 Table 27. Europe Gene Cloning Technology Services Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 28. Asia-Pacific Gene Cloning Technology Services Growth Accelerators and Market Barriers
 Table 29. Asia-Pacific Gene Cloning Technology Services Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 30. Central and South America Gene Cloning Technology Services Investment Opportunities and Key Challenges
 Table 31. Central and South America Gene Cloning Technology Services Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 32. Middle East and Africa Gene Cloning Technology Services Investment Opportunities and Key Challenges
 Table 33. Middle East and Africa Gene Cloning Technology Services Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 34. VectorBuilder Corporation Information
 Table 35. VectorBuilder Description and Major Businesses
 Table 36. VectorBuilder Product Features and Attributes
 Table 37. VectorBuilder Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 38. VectorBuilder Revenue Proportion by Product in 2024
 Table 39. VectorBuilder Revenue Proportion by Application in 2024
 Table 40. VectorBuilder Revenue Proportion by Geographic Area in 2024
 Table 41. VectorBuilder Gene Cloning Technology Services SWOT Analysis
 Table 42. VectorBuilder Recent Developments
 Table 43. BioServUK Corporation Information
 Table 44. BioServUK Description and Major Businesses
 Table 45. BioServUK Product Features and Attributes
 Table 46. BioServUK Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 47. BioServUK Revenue Proportion by Product in 2024
 Table 48. BioServUK Revenue Proportion by Application in 2024
 Table 49. BioServUK Revenue Proportion by Geographic Area in 2024
 Table 50. BioServUK Gene Cloning Technology Services SWOT Analysis
 Table 51. BioServUK Recent Developments
 Table 52. GenScript Corporation Information
 Table 53. GenScript Description and Major Businesses
 Table 54. GenScript Product Features and Attributes
 Table 55. GenScript Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 56. GenScript Revenue Proportion by Product in 2024
 Table 57. GenScript Revenue Proportion by Application in 2024
 Table 58. GenScript Revenue Proportion by Geographic Area in 2024
 Table 59. GenScript Gene Cloning Technology Services SWOT Analysis
 Table 60. GenScript Recent Developments
 Table 61. urofins Genomics Corporation Information
 Table 62. urofins Genomics Description and Major Businesses
 Table 63. urofins Genomics Product Features and Attributes
 Table 64. urofins Genomics Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 65. urofins Genomics Revenue Proportion by Product in 2024
 Table 66. urofins Genomics Revenue Proportion by Application in 2024
 Table 67. urofins Genomics Revenue Proportion by Geographic Area in 2024
 Table 68. urofins Genomics Gene Cloning Technology Services SWOT Analysis
 Table 69. urofins Genomics Recent Developments
 Table 70. Innoprot Corporation Information
 Table 71. Innoprot Description and Major Businesses
 Table 72. Innoprot Product Features and Attributes
 Table 73. Innoprot Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 74. Innoprot Revenue Proportion by Product in 2024
 Table 75. Innoprot Revenue Proportion by Application in 2024
 Table 76. Innoprot Revenue Proportion by Geographic Area in 2024
 Table 77. Innoprot Gene Cloning Technology Services SWOT Analysis
 Table 78. Innoprot Recent Developments
 Table 79. Genewiz Corporation Information
 Table 80. Genewiz Description and Major Businesses
 Table 81. Genewiz Product Features and Attributes
 Table 82. Genewiz Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 83. Genewiz Recent Developments
 Table 84. Bio-Fab Research Corporation Information
 Table 85. Bio-Fab Research Description and Major Businesses
 Table 86. Bio-Fab Research Product Features and Attributes
 Table 87. Bio-Fab Research Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 88. Bio-Fab Research Recent Developments
 Table 89. OriGene Corporation Information
 Table 90. OriGene Description and Major Businesses
 Table 91. OriGene Product Features and Attributes
 Table 92. OriGene Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 93. OriGene Recent Developments
 Table 94. Prospec-Tany Technogene Corporation Information
 Table 95. Prospec-Tany Technogene Description and Major Businesses
 Table 96. Prospec-Tany Technogene Product Features and Attributes
 Table 97. Prospec-Tany Technogene Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 98. Prospec-Tany Technogene Recent Developments
 Table 99. Addgene Corporation Information
 Table 100. Addgene Description and Major Businesses
 Table 101. Addgene Product Features and Attributes
 Table 102. Addgene Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 103. Addgene Recent Developments
 Table 104. Protein Ark Corporation Information
 Table 105. Protein Ark Description and Major Businesses
 Table 106. Protein Ark Product Features and Attributes
 Table 107. Protein Ark Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 108. Protein Ark Recent Developments
 Table 109. Protomnis Corporation Information
 Table 110. Protomnis Description and Major Businesses
 Table 111. Protomnis Product Features and Attributes
 Table 112. Protomnis Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 113. Protomnis Recent Developments
 Table 114. RD-Biotech Corporation Information
 Table 115. RD-Biotech Description and Major Businesses
 Table 116. RD-Biotech Product Features and Attributes
 Table 117. RD-Biotech Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 118. RD-Biotech Recent Developments
 Table 119. Charles River Corporation Information
 Table 120. Charles River Description and Major Businesses
 Table 121. Charles River Product Features and Attributes
 Table 122. Charles River Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 123. Charles River Recent Developments
 Table 124. Raw Materials Key Suppliers
 Table 125. Distributors List
 Table 126. Market Trends and Market Evolution
 Table 127. Market Drivers and Opportunities
 Table 128. Market Challenges, Risks, and Restraints
 Table 129. Research Programs/Design for This Report
 Table 130. Key Data Information from Secondary Sources
 Table 131. Key Data Information from Primary Sources


List of Figures
 Figure 1. Gene Cloning Technology Services Product Picture
 Figure 2. Global Gene Cloning Technology Services Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 3. Basic Gene Cloning Service Product Picture
 Figure 4. Custom Gene Cloning Services Product Picture
 Figure 5. Global Gene Cloning Technology Services Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 6. Laboratory
 Figure 7. Research Institute
 Figure 8. Others
 Figure 9. Gene Cloning Technology Services Report Years Considered
 Figure 10. Global Gene Cloning Technology Services Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 11. Global Gene Cloning Technology Services Revenue (2020-2031) & (US$ Million)
 Figure 12. Global Gene Cloning Technology Services Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Figure 13. Global Gene Cloning Technology Services Revenue Market Share by Region (2020-2031)
 Figure 14. Global Gene Cloning Technology Services Revenue Market Share Ranking (2024)
 Figure 15. Tier Distribution by Revenue Contribution (2020 VS 2024)
 Figure 16. Basic Gene Cloning Service Revenue Market Share by Player in 2024
 Figure 17. Custom Gene Cloning Services Revenue Market Share by Player in 2024
 Figure 18. Global Gene Cloning Technology Services Revenue Market Share by Type (2020-2031)
 Figure 19. Global Gene Cloning Technology Services Revenue Market Share by Application (2020-2031)
 Figure 20. North America Gene Cloning Technology Services Revenue YoY (2020-2031) & (US$ Million)
 Figure 21. North America Top 5 Players Gene Cloning Technology Services Revenue (US$ Million) in 2024
 Figure 22. North America Gene Cloning Technology Services Revenue (US$ Million) by Type (2020 - 2031)
 Figure 23. North America Gene Cloning Technology Services Revenue (US$ Million) by Application (2020-2031)
 Figure 24. US Gene Cloning Technology Services Revenue (2020-2031) & (US$ Million)
 Figure 25. Canada Gene Cloning Technology Services Revenue (2020-2031) & (US$ Million)
 Figure 26. Mexico Gene Cloning Technology Services Revenue (2020-2031) & (US$ Million)
 Figure 27. Europe Gene Cloning Technology Services Revenue YoY (2020-2031) & (US$ Million)
 Figure 28. Europe Top 5 Players Gene Cloning Technology Services Revenue (US$ Million) in 2024
 Figure 29. Europe Gene Cloning Technology Services Revenue (US$ Million) by Type (2020-2031)
 Figure 30. Europe Gene Cloning Technology Services Revenue (US$ Million) by Application (2020-2031)
 Figure 31. Germany Gene Cloning Technology Services Revenue (2020-2031) & (US$ Million)
 Figure 32. France Gene Cloning Technology Services Revenue (2020-2031) & (US$ Million)
 Figure 33. U.K. Gene Cloning Technology Services Revenue (2020-2031) & (US$ Million)
 Figure 34. Italy Gene Cloning Technology Services Revenue (2020-2031) & (US$ Million)
 Figure 35. Russia Gene Cloning Technology Services Revenue (2020-2031) & (US$ Million)
 Figure 36. Asia-Pacific Gene Cloning Technology Services Revenue YoY (2020-2031) & (US$ Million)
 Figure 37. Asia-Pacific Top 8 Players Gene Cloning Technology Services Revenue (US$ Million) in 2024
 Figure 38. Asia-Pacific Gene Cloning Technology Services Revenue (US$ Million) by Type (2020-2031)
 Figure 39. Asia-Pacific Gene Cloning Technology Services Revenue (US$ Million) by Application (2020-2031)
 Figure 40. Indonesia Gene Cloning Technology Services Revenue (2020-2031) & (US$ Million)
 Figure 41. Japan Gene Cloning Technology Services Revenue (2020-2031) & (US$ Million)
 Figure 42. South Korea Gene Cloning Technology Services Revenue (2020-2031) & (US$ Million)
 Figure 43. Australia Gene Cloning Technology Services Revenue (2020-2031) & (US$ Million)
 Figure 44. India Gene Cloning Technology Services Revenue (2020-2031) & (US$ Million)
 Figure 45. Indonesia Gene Cloning Technology Services Revenue (2020-2031) & (US$ Million)
 Figure 46. Vietnam Gene Cloning Technology Services Revenue (2020-2031) & (US$ Million)
 Figure 47. Malaysia Gene Cloning Technology Services Revenue (2020-2031) & (US$ Million)
 Figure 48. Philippines Gene Cloning Technology Services Revenue (2020-2031) & (US$ Million)
 Figure 49. Singapore Gene Cloning Technology Services Revenue (2020-2031) & (US$ Million)
 Figure 50. Central and South America Gene Cloning Technology Services Revenue YoY (2020-2031) & (US$ Million)
 Figure 51. Central and South America Top 5 Players Gene Cloning Technology Services Revenue (US$ Million) in 2024
 Figure 52. Central and South America Gene Cloning Technology Services Revenue (US$ Million) by Type (2020-2031)
 Figure 53. Central and South America Gene Cloning Technology Services Revenue (US$ Million) by Application (2020-2031)
 Figure 54. Brazil Gene Cloning Technology Services Revenue (2020-2025) & (US$ Million)
 Figure 55. Argentina Gene Cloning Technology Services Revenue (2020-2025) & (US$ Million)
 Figure 56. Middle East and Africa Gene Cloning Technology Services Revenue YoY (2020-2031) & (US$ Million)
 Figure 57. Middle East and Africa Top 5 Players Gene Cloning Technology Services Revenue (US$ Million) in 2024
 Figure 58. South America Gene Cloning Technology Services Revenue (US$ Million) by Type (2020-2031)
 Figure 59. Middle East and Africa Gene Cloning Technology Services Revenue (US$ Million) by Application (2020-2031)
 Figure 60. GCC Countries Gene Cloning Technology Services Revenue (2020-2025) & (US$ Million)
 Figure 61. Israel Gene Cloning Technology Services Revenue (2020-2025) & (US$ Million)
 Figure 62. Egypt Gene Cloning Technology Services Revenue (2020-2025) & (US$ Million)
 Figure 63. South Africa Gene Cloning Technology Services Revenue (2020-2025) & (US$ Million)
 Figure 64. Gene Cloning Technology Services Industry Chain Mapping
 Figure 65. Channels of Distribution (Direct Vs Distribution)
 Figure 66. Bottom-up and Top-down Approaches for This Report
 Figure 67. Data Triangulation
 Figure 68. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Bioinformatics Barcelona

RELATED REPORTS

Global In-service Inspection Services for Nuclear Facilities Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-33X20008
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Marketing Work Management Software Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-32Z20025
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Marketing Dashboard Software Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-33J20012
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Industrial CT Inspection Services Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-14Q20225
Wed Dec 03 00:00:00 UTC 2025

Add to Cart